ALMKT:EPA
Mauna Kea Technologies SA
€ 0.092
0.00%
(0.00) Siku 1
13 Nov, 17:35:01 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALMKT...
Fungua
€ 0.09
Juu
€ 0.10
Chini
€ 0.09
Mtaji wa soko
18.48M
Wastani wa kiasi cha mauzo
elfu 541.14
Kiasi cha mauzo ya hisa
elfu 75.16
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.79
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Fungua
€ 0.09
Juu
€ 0.10
Chini
€ 0.09
Mtaji wa soko
18.48M
Wastani wa kiasi cha mauzo
elfu 541.14
Kiasi cha mauzo ya hisa
elfu 75.16
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.79
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
24/7 Wall St.
·
dakika 29 zilizopita
The S&P 500 Has a "Pure Value" Version. RPV Gives Its Cheapest Stocks the Biggest Weights
TradingNEWS
·
dakika 30 zilizopita
Stock Market Today: S&P 500 7,510 (-1.1%), Nasdaq -1.9%, Dow DJI -0.3%; 7,845 Target as AMD -9.7%
24/7 Wall St.
·
dakika 27 zilizopita
S&P 500 Slides Nearly 1% at Midday as Tech Absorbs Most of the Hit
TradingView
·
saa 3 zilizopita
Wall Street Divided on S&P 500: Which ETFs Could Benefit in 2027?
Wasifu
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Kuhusu Mauna Kea Technologies SA
Afisa Mkuu Mtendaji (CEO)Sacha Loiseau
Wafanyakazi56
Lilianzishwa2000
Makao makuu-
SektaHealth Care
Sekta-
Tovutimaunakeatech.com